Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.

about

Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.

Item

http://www.wikidata.org/entity/Q49588315

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@en

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@nl

type

Item

label

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@en

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@nl

prefLabel

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@en

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@nl

P1476

Pathologic Response to Preoper ...... y and Duodenal Adenocarcinoma.

@en

P2093

Ching-Wei Tzeng

http://www.w3.org/2001/XMLSchema#string

Claire Goumard

http://www.w3.org/2001/XMLSchema#string

Claudius Conrad

http://www.w3.org/2001/XMLSchema#string

Huamin Wang

http://www.w3.org/2001/XMLSchema#string

Jason B Fleming

http://www.w3.org/2001/XMLSchema#string

Jean-Nicolas Vauthey

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Lee

http://www.w3.org/2001/XMLSchema#string

Jun Zhao

http://www.w3.org/2001/XMLSchema#string

Masayuki Okuno

http://www.w3.org/2001/XMLSchema#string

Matthew H Katz

http://www.w3.org/2001/XMLSchema#string

P2860

The cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG) regimen in advanced biliary tract adenocarcinoma.

A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.

Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.

RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.

Survival in ampullary cancer: potential role of different KRAS mutations.

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome

P2888

s10434-017-6098-6

P304

3954-3963

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-6098-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092063790

http://www.w3.org/2001/XMLSchema#string

P698

28980211

http://www.w3.org/2001/XMLSchema#string

P932

6039188

http://www.w3.org/2001/XMLSchema#string